21-hydroxylase deficiency (patient information): Difference between revisions

Jump to navigation Jump to search
Line 49: Line 49:


==Prevention of congenital adrenal hyperplasia due to 21-hydroxylase deficiency==
==Prevention of congenital adrenal hyperplasia due to 21-hydroxylase deficiency==
Prognosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency are usually good. But when adrenal crisis happens and is untreated, the patient may die within 1 - 6 weeks after birth.


==What to expect (Outook/Prognosis)?==
==What to expect (Outook/Prognosis)?==

Revision as of 17:16, 1 December 2009

For the WikiDoc page for this topic, click here

WikiDoc Resources for 21-hydroxylase deficiency (patient information)

Articles

Most recent articles on 21-hydroxylase deficiency (patient information)

Most cited articles on 21-hydroxylase deficiency (patient information)

Review articles on 21-hydroxylase deficiency (patient information)

Articles on 21-hydroxylase deficiency (patient information) in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on 21-hydroxylase deficiency (patient information)

Images of 21-hydroxylase deficiency (patient information)

Photos of 21-hydroxylase deficiency (patient information)

Podcasts & MP3s on 21-hydroxylase deficiency (patient information)

Videos on 21-hydroxylase deficiency (patient information)

Evidence Based Medicine

Cochrane Collaboration on 21-hydroxylase deficiency (patient information)

Bandolier on 21-hydroxylase deficiency (patient information)

TRIP on 21-hydroxylase deficiency (patient information)

Clinical Trials

Ongoing Trials on 21-hydroxylase deficiency (patient information) at Clinical Trials.gov

Trial results on 21-hydroxylase deficiency (patient information)

Clinical Trials on 21-hydroxylase deficiency (patient information) at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on 21-hydroxylase deficiency (patient information)

NICE Guidance on 21-hydroxylase deficiency (patient information)

NHS PRODIGY Guidance

FDA on 21-hydroxylase deficiency (patient information)

CDC on 21-hydroxylase deficiency (patient information)

Books

Books on 21-hydroxylase deficiency (patient information)

News

21-hydroxylase deficiency (patient information) in the news

Be alerted to news on 21-hydroxylase deficiency (patient information)

News trends on 21-hydroxylase deficiency (patient information)

Commentary

Blogs on 21-hydroxylase deficiency (patient information)

Definitions

Definitions of 21-hydroxylase deficiency (patient information)

Patient Resources / Community

Patient resources on 21-hydroxylase deficiency (patient information)

Discussion groups on 21-hydroxylase deficiency (patient information)

Patient Handouts on 21-hydroxylase deficiency (patient information)

Directions to Hospitals Treating 21-hydroxylase deficiency (patient information)

Risk calculators and risk factors for 21-hydroxylase deficiency (patient information)

Healthcare Provider Resources

Symptoms of 21-hydroxylase deficiency (patient information)

Causes & Risk Factors for 21-hydroxylase deficiency (patient information)

Diagnostic studies for 21-hydroxylase deficiency (patient information)

Treatment of 21-hydroxylase deficiency (patient information)

Continuing Medical Education (CME)

CME Programs on 21-hydroxylase deficiency (patient information)

International

21-hydroxylase deficiency (patient information) en Espanol

21-hydroxylase deficiency (patient information) en Francais

Business

21-hydroxylase deficiency (patient information) in the Marketplace

Patents on 21-hydroxylase deficiency (patient information)

Experimental / Informatics

List of terms related to 21-hydroxylase deficiency (patient information)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Jinhui Wu, MD

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

What is congenital adrenal hyperplasia due to 21-hydroxylase deficiency?

How do I know if I have congenital adrenal hyperplasia due to 21-hydroxylase deficiency and what are the symptoms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency?

Signs and symptoms in infants: In this form of congenital adrenal hyperplasia, newborns develop severe symptoms shortly after birth due to loss of salt.

Signs and symptoms of adrenal hyperplasia in children and adults: Girls will usually have normal internal female reproductive organs as normal girls. But some of their external appearance may change. Boys won't have any obvious problems at birth. However, they may have 2~3 years early virilizing characteristics than normal boys.

  • Irregular or absent menstruation in girls
  • Ambiguous genitalia or virilizing characteristics in girls, often appearing more male than female: Deep voice, early appearance of pubic and armpit hair, excessive hair growth and facial hair
  • Early appearance of masculine characteristics in boys: Deep voice, early appearance of pubic and armpit hair, enlarged penis, small testes, well-developed muscles
  • Rapid growth during childhood, but shorter than average final height
  • Infertility
  • Low bone density

Who is at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency?

Mutations in the CYP21A2 gene cause congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

How to know you have congenital adrenal hyperplasia due to 21-hydroxylase deficiency?

  • Blood or urine levels of hormones or their metabolites: In patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, doctors may see abnormal serum electrolytes and urine electrolytes, high levels of 17-OH progesterone, high levels of serum DHEA sulfate, high levels of urinary 17-ketosteroids, low levels of aldosterone and cortisol, normal or low urinary 17-hydroxycorticosteroids.
  • X-ray for bone age: This can be done in the department of radiation. It shows older bones than normal for the person's age.
  • Gene detection: This may be the most accurate test for the diagnosis. In patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, mutations of CYP21A2 gene can be detected.

When to seek urgent medical care?

Contact your doctor if your child has signs and symptoms that seem to suggest congenital adrenal hyperplasia due to 21-hydroxylase deficiency. For the women who may carry the mutate gene, you need to talk with your doctor, obtain appropriate information about the condition and the risk of having an affected child, and to decide on whether to have children.

Treatment options

The goal of treatment is to return hormone levels to normal. The treatment is steroid therapy. Talk to you or your kid's doctor about side effects and your family's preferences.

  • Determination the gender of a baby: When the baby with ambiguous genitalia born, the health care provider will determine the gender by checking the chromosomes.
  • Medicines: Patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency nedd to add a form of cortisol, such as dexamethasone, fludrocortisone, or hydrocortisone every day. During times of stress, such as severe illness or surgery, they may need additional doses of medicine.

Diseases with similar symptoms

Where to find medical care for congenital adrenal hyperplasia due to 21-hydroxylase deficiency?

Directions to Hospitals Treating congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Prevention of congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Prognosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency are usually good. But when adrenal crisis happens and is untreated, the patient may die within 1 - 6 weeks after birth.

What to expect (Outook/Prognosis)?

Copyleft Sources

http://www.mayoclinic.com/print/congenital-adrenal-hyperplasia/DS00915/METHOD=print&DSECTION=all

http://ghr.nlm.nih.gov/condition=21hydroxylasedeficiency

http://www.nlm.nih.gov/medlineplus/ency/article/000411.htm

http://www.magicfoundation.org/www/docs/100/congenital_adrenal_hyperplasia.html

Template:WH Template:WS